Our results indicated that atractylodin could reduce the weight loss of mice with UC, control diarrhea and hematochezia, alleviate trauma to the colon, reduce the loss of colonic goblet cells, and increase the expression of MUC2, ZO-1, and occludin. This evidence concerns the gene TJP1 and Hematochezia.